ZA200900483B - Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins - Google Patents

Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins

Info

Publication number
ZA200900483B
ZA200900483B ZA200900483A ZA200900483A ZA200900483B ZA 200900483 B ZA200900483 B ZA 200900483B ZA 200900483 A ZA200900483 A ZA 200900483A ZA 200900483 A ZA200900483 A ZA 200900483A ZA 200900483 B ZA200900483 B ZA 200900483B
Authority
ZA
South Africa
Prior art keywords
construction
mediated insertion
vector
recombinant virus
immunologic determinants
Prior art date
Application number
ZA200900483A
Inventor
Konstantin V Pugachev
Alexander A Rumyantsev
Original Assignee
Sanofi Pasteur Biologics Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Biologics Co filed Critical Sanofi Pasteur Biologics Co
Publication of ZA200900483B publication Critical patent/ZA200900483B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200900483A 2006-07-14 2007-07-16 Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins ZA200900483B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83101306P 2006-07-14 2006-07-14

Publications (1)

Publication Number Publication Date
ZA200900483B true ZA200900483B (en) 2010-03-31

Family

ID=41095676

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900483A ZA200900483B (en) 2006-07-14 2007-07-16 Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins

Country Status (2)

Country Link
CN (1) CN101528254A (en)
ZA (1) ZA200900483B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101850116B (en) * 2010-06-18 2012-07-04 中国人民解放军军事医学科学院军事兽医研究所 Method for constructing virus live vector recombinant vaccine by utilizing transposon
CN103328647B (en) * 2010-09-21 2016-05-04 廖经伦 Flavivirus recombinant and application thereof
EP2959915A1 (en) * 2014-06-23 2015-12-30 Institut Pasteur A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection
EP3302574A4 (en) * 2015-05-26 2018-10-17 Advaxis, Inc. Personalized delivery vector-based immunotherapy and uses thereof
CN105400799B (en) * 2015-12-22 2018-12-28 成都生物制品研究所有限责任公司 A kind of hot embedded virus of encephalitis/Huang and its preparation method and application

Also Published As

Publication number Publication date
CN101528254A (en) 2009-09-09

Similar Documents

Publication Publication Date Title
IL196523A0 (en) Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
HRP20181259T1 (en) Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells
HK1210410A1 (en) Stabilization of vaccines by lyophilization
BRPI1012635A2 (en) "methods and compositions for virus immunization"
EP2035565A4 (en) Methods of enhancing protein incorporation into virus like particles
IL195683A0 (en) Recombinant viral vaccine
EP2396343A4 (en) Modified virus vectors and methods of making and using the same
IL208147A0 (en) Replication-defective flavivirus vaccines and vaccine vectors
IL208241A0 (en) Heat shock protein gp96 vaccination and methods of using same
PL2010209T3 (en) Immunogenic wt-1 peptides and methods of use thereof
IL198186A (en) Mphosph1 derived peptide vaccines
PL2419132T3 (en) Recombinant avian herpes virus vectors and vaccine for immunizing waterfowl species
EP2234636A4 (en) Stabilized formulations of peptides and proteins
EP2001517A4 (en) Regulated expression of recombinant proteins from adeno-associated viral vectors
SMT201600147B (en) METHODS TO IMPROVE THE EXPRESSION OF RECOMBINANT PROTEINS
ZA200900483B (en) Construction of recombinant virus vaccines by direct transposon-mediated insertion of foreign immunologic determinants into vector virus proteins
EP1934335A4 (en) Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
GB0615635D0 (en) Immunogenic proteins and uses thereof
EP2134361A4 (en) Compositions and methods for increasing immunogenicity of glycoprotein vaccines
IL232461A0 (en) Melk epitope peptides and vaccines containing the same
ZA201104013B (en) Recombinant inactivated viral vector vaccine
EP1841451A4 (en) Peptides for delivery of mucosal vaccines
ZA201101743B (en) Vaccine comprising protein nmbo964 from meisseria meningitidis
BRPI1013938A2 (en) "ttk peptides and vaccines including them"
EP2054081A4 (en) Jc virus vaccine